Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. 111.87), arrhythmias were detected in 9 (33%) patients. We did not identify significant risk factors for arrhythmias post-HT.

Heart Transplant 59

Heart Transplant Transplant Arrhythmia Pacemaker 59

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

Circulation

NOVEMBER 11, 2024

The most common MAE was arrhythmia, representing 46% of MAE, followed by cardiac arrest and bleeding each 20%. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Circulation

NOVEMBER 11, 2024

months, no deaths, left ventricular failure, malignant arrhythmias, tumor recurrence were observed in the other patients.Conclusion:Our modified ventricular reconstruction procedure has proven successful. 2 steps were performed during modified ventricular reconstruction procedure. During a median follow-up period of 17.4

Pediatrics 40

Pediatrics Outcomes Heart Transplant Aneurysm 40